Cell proliferation pathway

The "cell proliferation pathway" refers collectively to multiple molecular signaling cascades that govern the ability of cells to divide and grow. Major pathways involved in cell proliferation regulation include the RAS/RAF/MAPK, PI3K/AKT/mTOR, JAK/STAT, Wnt, Notch, and Hedgehog signaling networks, among others[2][3][4][6][8]. Each pathway is made up of numerous protein components—such as kinases, transcription factors, and membrane receptors—which act in concert to promote or inhibit progression through the cell cycle[3][6]. Dysregulation of these pathways is a hallmark of many cancers and other diseases characterized by abnormal cell growth[2][4][6]. Clinical drug development focuses on inhibitors targeting specific components of these pathways (for example, MEK inhibitors, CDK inhibitors, JAK inhibitors, etc.) rather than the broad and indistinct entity of the "cell proliferation pathway" as a whole[2][4][8]. Therefore, "cell proliferation pathway" is a conceptual framework, not a distinct, druggable target. Key reason for is_incorrect = true: "Cell proliferation pathway" is not a unique molecule, receptor, or even a defined molecular entity; it is a collective term for multiple interconnected signaling pathways. As such, it is too broad to be a canonical therapeutic target, and targeted drug development requires focus on specific molecules (such as "Epidermal growth factor receptor", "Cyclin-dependent kinase 4", etc.) rather than the pathway concept as a whole[2][3][4][6][8]. If further information is desired for a specific signaling molecule or pathway within the cell proliferation context (e.g., "RAS/RAF/MAPK pathway", "Cyclin-dependent kinase 4"), a more targeted query will yield druggable and structurally detailed entities.

Other names

Cell proliferation signaling pathwayProliferation pathwaysCell growth pathways